Abstract
The pharmaceutical industry widely uses amorphous formulations to improve the low oral bioavailability of many BCS (biopharmaceutical classification system) class II drugs. This project aims to study the local structure of amorphous solid dispersions of poorly soluble drugs, focusing specifically on the structural aspects that may help select polymers that ensure efficient amorphization a…